World Cancer Day – Joining efforts for a better cancer care

World cancer day, celebrated on the 4th of February, was established more than 20 years ago. It represents an initiative of the Union for International Cancer Control (UICC) , the oldest and largest global membership organization dedicated to taking action on cancer. UICC has over 1150 member organizations in 172 countries and territories. Its mission is to reduce the global cancer burden, promote equity and awareness, ensuring that cancer control continues to be a priority in the world health and development agenda. 

More than half of oncologic patients receive radiation therapy as part of their treatment. Intelligent and comprehensive solutions offered by MVision AI actively support radiation oncology professionals to increase their productivity and improve their knowledge, in the best interest of cancer patients.

According to the World Health Organization, cancer is diagnosed in 18 million people every year, globally, and the numbers are expected to double by 2050. 

Extensive efforts are made to treat it in the best possible way and offer patients a chance to cure or extend their life for many years from diagnosis. Another important aim in oncology is to preserve and improve their quality of life, regardless of the stage of the disease.

Treating cancer implies joint actions of patients, their caregivers and health professionals. Unfortunately, access to adequate healthcare is not always available. Comprehensive treatments are available in 90% of the high-income countries but only 15% from low-income countries.  Closing the care gap is one of the main priorities of international societies and public health structures.

Substantial budget, but also a high level of education and intelligent solutions are needed to improve cancer care. Delivering quality radiation therapy in a timely manner is hampered by insufficient infrastructure or staff shortage. Implementing artificial intelligence in Radiation Oncology already demonstrated promising results for improving the complex process of treatment preparation and delivery.

MVision AI offers intelligent and comprehensive solutions for a fast, precise and standardized treatment. Improved efficiency allows professionals to better use their time, for example interacting more time with patients or improving their skills. It also is beneficial from the logistic perspective, enabling the clinics to treat a higher number of patients, if needed, and lowering the waiting times. Such upgrades are increasingly used in clinical practice, and probably will become part of the gold standard in the next future.

References

  1. World cancer day. https://www.worldcancerday.org/our-story
  2. UICC. https://www.uicc.org/who-we-are/about-uicc
  3. WHO. Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer
  4. Worldwide cancer data. https://www.wcrf.org/cancer-trends/worldwide-cancer-data/#:~:text=Find%20information%20about%20world%20cancer,and%208.8%20million%20in%20women.
  5. Abdel-Wahab M, Gondhowiardjo SS, Rosa AA, et al. Global Radiotherapy: Current Status and Future Directions-White Paper. JCO Glob Oncol. 2021;7:827-842. doi:10.1200/GO.21.00029

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

20.11.2024

MVision AI Ranked Among the Top 10 in Deloitte Technology Fast 50 Finland for 2024

Helsinki, Finland, 20 November 2024 – MVision AI, a leading innovator in AI-driven solutions for oncology, is proud to announce its recognition among the top ten companies in the Deloitte Technology Fast 50 Finland 2024 ranking. This prestigious award acknowledges MVision AI's rapid growth and its mission-driven advancements in making…

Press Releases

7.11.2024

Safe and Ethical AI in Radiation Oncology: Regulations and MVision’s Compliance

Technology is evolving, and the same applies to Radiation Oncology. New ways and new tools require new rules. Artificial intelligence (AI)  brings tremendous potential, so the world has to learn how to get the best of it, safely.  Al systems identified as high-risk have to comply with strict requirements, including…

Articles

24.10.2024

MVision AI Secures FDA 510(k) Clearance for Contour+ Advanced CT and MR Models

Helsinki, October 2024 – MVision AI, a leading innovator in AI-powered solutions for radiotherapy, is thrilled to announce that its auto-contouring solution Contour+ has received FDA 510(k) clearance for three new models: Bones CT, Brain MR, and Male Pelvis MR T2, and five updated models: Brain CT, Abdomen & Lung…

Press Releases